Author

C. E. Joshu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. M. De Marzo· 2 shared J. Lu· 2 shared J. P. Maynard· 2 shared K. S. Sfanos· 2 shared T. L. Lotan· 2 shared A. M. Carter· 1 shared C. M. Heaphy· 1 shared H. Hempel Sullivan· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. M. De Marzo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJun 4, 2021

P2X4 Purinergic Receptors as a Therapeutic Target in Aggressive Prostate Cancer

J. P. Maynard, J. Lu, I. Vidal…·K. S. Sfanos

This study identifies P2X4 purinergic receptors as a driver of aggressive prostate cancer and a potential therapeutic target through in vitro and in vivo experiments.

DOI 10.1002/path.5815

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivJul 23, 2020

Differential Mast Cell Phenotypes in Benign versus Cancer Tissues and Prostate Cancer Oncologic Outcomes

H. Hempel Sullivan, J. P. Maynard, C. M. Heaphy…·K. S. Sfanos

The paper investigates differential mast cell phenotypes in benign and cancerous prostate tissues and links higher numbers of tryptase-only mast cells to worse oncologic outcomes.

DOI 10.1002/path.5606

humanbulk RNA-seq

𝕏 PostBluesky